Dopamine beta hydroxylase Blocking Peptide

Catalog no. P-DBH · Research Use Only

$155 per 250 µg. Ships within 2–3 business days from the U.S.

P-DBH — affinity-purified Rabbit antibody against Dopamine beta hydroxylase. Validated for Immunodepletion, Immunocompetition. Reacts with Human, Mouse, Rat.

Specifications

Catalog numberP-DBH
TargetDopamine beta hydroxylase
HostRabbit
ReactivityHuman, Mouse, Rat
ApplicationsImmunodepletion, Immunocompetition
ConjugateUnconjugated
ImmunogenSynthetic peptide taken within amino acid region 125-178 on mouse Dopamine beta hydroxylase.
Size250 µg
Storage-20°C
UniProtQ64237

About this target

Dopamine beta hydroxylase Blocking Peptide is the antigenic blocking peptide for the Dopamine beta hydroxylase antibody DBH-101AP. Pre-incubating the antibody with the peptide competes away specific binding, which helps confirm that a signal comes from the intended target. Supplied at 250 µg, for research use only. Catalyzes the hydroxylation of dopamine to noradrenaline (also known as norepinephrine), and is thus vital for regulation of these neurotransmitters. Subcellular location: [Soluble dopamine beta-hydroxylase]: Cytoplasmic vesicle, secretory vesicle lumen. Cytoplasmic vesicle, secretory vesicle, chromaffin granule lumen.; SUBCELLULAR LOCATION: Cytoplasmic vesicle, secretory vesicle membrane; Single-pass type II membrane protein.

Documents

Related products

FabGennix International, Inc., 9191 Kyser Way, Frisco, TX 75033. For research use only. Not for diagnostic or therapeutic use.